BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19346878)

  • 1. In vitro inferiority of ceftazidime compared with other beta-lactams for viridans group Streptococcus bacteremia in pediatric oncology patients: implications for antibiotic choices.
    Paulus S; Dobson S; Rassekh S; Blondel-Hill E
    J Pediatr Hematol Oncol; 2009 Apr; 31(4):267-9. PubMed ID: 19346878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
    Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
    BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
    Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
    J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients.
    Shelburne SA; Lasky RE; Sahasrabhojane P; Tarrand JT; Rolston KV
    Clin Infect Dis; 2014 Jul; 59(2):223-30. PubMed ID: 24755857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viridans group streptococcal infections among children with cancer and the importance of emerging antibiotic resistance.
    Bruckner L; Gigliotti F
    Semin Pediatr Infect Dis; 2006 Jul; 17(3):153-60. PubMed ID: 16934710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic susceptibility of Gram-negatives isolated from bacteremia in children with cancer. Implications for empirical therapy of febrile neutropenia.
    Castagnola E; Caviglia I; Pescetto L; Bagnasco F; Haupt R; Bandettini R
    Future Microbiol; 2015; 10(3):357-64. PubMed ID: 25812459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics.
    Presterl E; Grisold AJ; Reichmann S; Hirschl AM; Georgopoulos A; Graninger W
    J Antimicrob Chemother; 2005 Jan; 55(1):45-50. PubMed ID: 15563519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency of streptococcal bacteraemia during childhood AML therapy irrespective of dose of cytarabine.
    Johannsen KH; Handrup MM; Lausen B; Schrøder H; Hasle H
    Pediatr Blood Cancer; 2013 Jul; 60(7):1154-60. PubMed ID: 23281248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of 21 antimicrobial agents alone and in combination with aminoglycosides or fluoroquinolones against extended-spectrum-β-lactamase-producing Escherichia coli isolates causing bacteremia.
    Cha MK; Kang CI; Kim SH; Cho SY; Ha YE; Wi YM; Chung DR; Peck KR; Song JH;
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5834-7. PubMed ID: 26124174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility survey of piperacillin/tazobactam and some beta-lactam comparators in Italy.
    Stefani S; Bonfiglio G; Bianchi C; Zollo A; Nicoletti G
    Drugs Exp Clin Res; 1998; 24(2):105-13. PubMed ID: 9675551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and antibiotic susceptibility of viridans streptococcal bacteremia in children with febrile neutropenia.
    Han SB; Bae EY; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B; Kang JH; Kim HK
    Infection; 2013 Oct; 41(5):917-24. PubMed ID: 23640200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility of blood culture isolates of viridans streptococci: relationship to a change in empirical antibiotic therapy in febrile neutropenia.
    Kennedy HF; Gemmell CG; Bagg J; Gibson BE; Michie JR
    J Antimicrob Chemother; 2001 May; 47(5):693-6. PubMed ID: 11328787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of cefepime and ceftazidime against 197 nosocomial blood stream isolates of streptococci: a multicenter sample.
    Pfaller MA; Marshall SA; Jones RN
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):273-6. PubMed ID: 9458985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and outcomes of viridans group streptococcal infections in pediatric acute myeloid leukemia: from the Canadian infections in AML research group.
    Lewis V; Yanofsky R; Mitchell D; Dix D; Ethier MC; Gillmeister B; Johnston D; Michon B; Stobart K; Portwine C; Silva M; Cellot S; Price V; Bowes L; Zelcer S; Brossard J; Beyene J; Sung L
    Pediatr Infect Dis J; 2014 Feb; 33(2):126-9. PubMed ID: 24064558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viridans group streptococci bloodstream infections in neutropenic adult patients with hematologic malignancy: Single center experience.
    Radocha J; Paterová P; Zavřelová A; Víšek B; Gabalec F; Žemličková H; Žák P
    Folia Microbiol (Praha); 2018 Mar; 63(2):141-146. PubMed ID: 28776170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viridans Group Streptococcal Infections in Children After Chemotherapy or Stem Cell Transplantation: A 10-year Review From a Tertiary Pediatric Hospital.
    Nielsen MJ; Claxton S; Pizer B; Lane S; Cooke RPD; Paulus S; Carrol ED
    Medicine (Baltimore); 2016 Mar; 95(9):e2952. PubMed ID: 26945409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced susceptibility to penicillin of viridans group streptococci in the oral cavity of patients with haematological disease.
    Westling K; Julander I; Ljungman P; Heimdahl A; Thalme A; Nord CE
    Clin Microbiol Infect; 2004 Oct; 10(10):899-903. PubMed ID: 15373884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group.
    Pfaller MA; Jones RN; Marshall SA; Edmond MB; Wenzel RP
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):259-63. PubMed ID: 9458983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viridans streptococcus bacteremia in children on chemotherapy for cancer: an underestimated problem.
    Ahmed R; Hassall T; Morland B; Gray J
    Pediatr Hematol Oncol; 2003 Sep; 20(6):439-44. PubMed ID: 14631617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF).
    Maeda Y; Elborn JS; Parkins MD; Reihill J; Goldsmith CE; Coulter WA; Mason C; Millar BC; Dooley JS; Lowery CJ; Ennis M; Rendall JC; Moore JE
    J Cyst Fibros; 2011 Mar; 10(2):133-9. PubMed ID: 21145793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.